Ireland· IE-PA-EU/1/07/387/003-006
Advagraf 1 mg prolonged-release hard capsules
A l04aa05 product containing tacrolimus, registered in Ireland by Astellas Pharma Europe BV. The same ATC class is registered in 2 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
L04aa05 is registered in 2 of 19 countries.
Countries holding a registration under ATC L04AA05 (l04aa05), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 1 of them publish a price we can compare per daily dose
L04aa05 · ATC L04AA05
2 / 19 countries
- Ireland
- Polandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Tacrolimus
- Manufacturer
- Astellas Pharma Europe BV
- Country
- Ireland (IE)
- ATC code
- L04AA05
- ATC class
- L04AA05
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/07/387/003-006
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
L04aa05 in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaADVAGRAFAstellas Pharma Europe B.V., Leiden
- United KingdomAdvagraf 1mg modified-release capsulesWaymade Healthcare Plc
- FinlandAdvagrafAbacus Medicine A/S
- SpainADVAGRAF 1 MG CAPSULAS DURAS DE LIBERACION PROLONGADAAstellas Pharma Europe B.V.
- NetherlandsAdvagraf 1 mg, capules met verlengde afgifte, hardAstellas Pharma GmbH
- PolandAdvagrafAstellas Pharma Europe B.V.
- SwedenAdvagraf 1 mg Depotkapsel, hårdAstellas Pharma Europe BV
- BelgiumAdvagraf 1 mgAstellas Pharma Europe
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Adport, Dailiport
- Belgium · Adoport, Dailiport
- Bulgaria · Програф
- Cyprus · Prograf, Tacrolimus Accord
- Czechia · Dailiport, Gecrol
- Germany · Crilomus, Dailiport
- Denmark · Adport, Dailiport
- Estonia · Dailiport, Lebsanan
- Spain · Adoport, Cellmune
- Finland · Adport, Adport,
- France · Adoport, Conferoport
- United Kingdom (Northern Ireland) · Adoport, Ascezo
- Greece · Atodrit-Dermo, Eczatope Derm
- Croatia · Atezyrix, Dermitopic
- Hungary · Prograf, Tacrolimus Stada
- Iceland · Advagraf, Dailiport
- Italy · Adoport, Carelimus
- Liechtenstein · Advagraf, Envarsus
- Lithuania · Dailiport, Lebsanan
- Luxembourg · Prograft, Sumilor
- Latvia · Dailiport, Lebsanan
- Malta · Prograf
- Netherlands · Adport, Conferoport
- Norway · Adport, Advagraf
- Poland · Cidimus, Dailiport
- Portugal · Adoport, Dermitopic
- Romania · Prograf, Tacrolimus Sandoz
- Sweden · Adport, Adport,
- Slovenia · Adoport, Dailiport
- Slovakia · Atezyrix, Dailiport
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/522682a7-0e62-4ee3-9264-a718f844ad45 GET /v1/drugs/522682a7-0e62-4ee3-9264-a718f844ad45?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Prolonged-release capsule, hard",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"L04AA",
"L04AA05"
],
"strength": null,
"pa_number": "EU/1/07/387/003-006",
"substances": [
"Tacrolimus"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": null,
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about l04aa05.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.